On The Pen: The Weekly Dose 6.4.24

Send us a texthttps://ro.co/weight-loss/supply-trackerhttps://www.youtube.com/watch?v=mL_krAas70kNovo Nordisk Advertising:Novo Nordisk launches new advertising campaign "The Power of Wegovy"This advertisement includes the new indication for reduction of cardiovascular riskFor 2023, the #5 advertising spend for a drug was Rybelsus at $191 million.  The #6 advertising spend was Ozempic at $187.4 million (increase of 6% from 2022). More than 40% of the 2023 ad spend for Ozempic  went to online video platforms (i.e. social media like youtube)Link: https://www.youtube.com/watch?v=dhretLXYkZ4Structure Therapeutics GSBR-1290GSBR-1290 is a small molecule GLP-1 pillIn a 12-week phase 2 clinical study, a tablet formulation of GSBR-1290 had a weight-loss of 6.9%. This is comparable to Eli Lilly's phase 2 results for olforglipronAt Week 12, 67% of GSBR-1290 treated participants achieved ≥6% weight loss and 33% achieved ≥ 10% weight loss, compared to 0% for placeboAlso developing next generation combination GLP-1 candidates together with GIP, amylin, glucagon and apelin oral small moleculesLink (Madison Muller): https://www.bloomberg.com/news/articles/2024-06-03/structure-reports-early-oral-weight-loss-drug-data-adding-allureElon musk tweet:Elon Musk tweeted: Just make a lot of Ozempic/Mounjaro. It’s not inherently expensive. The health benefits of reducing obesity far exceed the downside of GLP-1 inhibitors. We evolved under starving conditions and now make food that is plentiful and delicious. Whether that food is “processed” does matter, but is not a game changerThis tweet has currently been seen 325,500 timesShanghai Stem Cell Type 2 Diabetes Treatmenthttps://www.scmp.com/news/china/science/article/3263878/chinese-scientists-report-world-first-they-cure-patients-diabetes-cell-therapyOnthepen.TVSupport the showMY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinSOCIAL LINKShttps://www.tiktok.com/@manonthemounjarohttps://twitter.com/ManOnMounjarohttps://instagram.com/manonthemounjarohttps://facebook.com/manonthemounjaro📲 Contact Me: MounjaroMan@gmail.com📼 PLAYLISTS:🖊️ ON THE PEN LIVES:https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM👀 WATCH MY MOUNJARO JOURNEY IN ORDER:https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW🚨📰 ALL THE LATEST MOUNJARO NEWS:https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yBThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.